Eight people die in Tanzania due to possible Marburg virus disease: WHO
At least eight people have died in Tanzania of suspected Marburg Virus Disease (MVD) and the regional risk is “high,” according to a
Health
Medical
Pharma
Drugs
Medical
Research
India’s Tata Group grants $57.8 million to build medical school in IT capital
Tata Group, a $165 billion Indian conglomerate, is set to build a medical school in the southern technology hub of Bengaluru by partnering
Drugs
Health
Pharma
Daiichi Sankyo to buy cancer antibody from Glycotope for $132.5 million
Daiichi Sankyo will buy outright a cancer antibody it had licensed from Glycotope GmbH earlier for $132.5 million, according to a statement from
Drugs
Health
Medical
Eli Lilly to buy Scorpion Therapeutics’ cancer drug for $2.5 billion
Eli Lilly and Company will acquire Scorpion Therapeutics’ investigational cancer drug, currently being evaluated in first- mid-stage trials to treat breast and solid
Drugs
Medical
Pharma
Johnson & Johnson to acquire Intra-Cellular Therapies Inc., for $14.6 billion
Johnson & Johnson will acquire Intra-Cellular Therapies Inc., a biopharmaceutical company developing drugs for central nervous system disorders, for $14.6 billion, according to
Health
Medical
Research
Easy access to green spaces may solve screen addiction problems in kids
Bharti Jayshankar January 11, 2024: Excessive screen time of children is a growing concern as many studies have correlated cognitive and language skills
Drugs
Pharma
Research
Pfizer’s experimental drug improves survival rates in hard-to-treat bladder cancer
Bharti Jayshankar January 11, 2024: In a breakthrough for bladder cancer treatment, Pfizer’s experimental anti-PD-1 therapy demonstrated superior efficacy compared to the current
Drugs
Medical
Pharma
Biogen Inc., to buy 62m outstanding shares of Sage for $441.7 million
Biogen Inc., plans to buy all outstanding shares totalling 61.17 million of Sage Therapeutics Inc., for $7.22 a share, representing a premium of
Drugs
Health
Pharma
Vertex, China’s Zai to develop, commercialise kidney disease drug
US-based Vertex Pharmaceutical Inc. has signed a licensing pact with China’s Zai Lab Ltd. to develop and commercialise the Boston-headquartered company’s medicine, which
Drugs
Health
Medical
Pfizer’s trial antibody for type of bladder cancer meets main goal
Pizer Inc.’s late-stage trial of an antibody treatment for a certain type of bladder cancer has shown significant improvement in time patients remained